Stem Cell and Regenerative Medicine in Minnesota: What’s Legal and What to Know

Last reviewed: 5/26 · Verify current state guidance before relying on any specific claim

Minnesota is one of the most research-significant states in American regenerative medicine, anchored by the Mayo Clinic Center for Regenerative Biotherapeutics (formerly the Center for Regenerative Medicine) in Rochester and the University of Minnesota Stem Cell Institute in Minneapolis. The state operates a legislative initiative — Regenerative Medicine Minnesota — that supports research, technology development, education, and patient care in regenerative medicine. Minnesota adopted a Right to Try law (commonly cited as the 2015 session) and is also the institutional home of one of the country’s most prominent academic critics of unregulated stem cell commercial practice, Leigh Turner of the University of Minnesota Center for Bioethics. The Minnesota Board of Medical Practice regulates physicians.

For the federal framework that applies in every state — FDA regulation of cell and tissue products under 21 CFR Part 1271, the 361/351 distinction, FDA enforcement history, and the federal Right to Try Act — see How Regenerative Medicine Is Regulated in the United States.

Regenerative Medicine Minnesota

Regenerative Medicine Minnesota is a state-funded initiative established by the Minnesota Legislature to support the development of regenerative medicine across research, technology, education, and patient care. The program funds projects at Minnesota institutions through annual competitive awards.

The initiative reflects a deliberate state-level investment in legitimate regenerative medicine infrastructure — comparable in spirit, if smaller in scale, to Maryland’s Stem Cell Research Fund or California’s CIRM. It does not directly regulate commercial clinical practice; it shapes the research and translational ecosystem around it.

The Minnesota Board of Medical Practice

The Minnesota Board of Medical Practice licenses and regulates allopathic and osteopathic physicians, physician assistants, and several allied practitioner categories. The Board operates under Minnesota Statutes Chapter 147.

As of late 2025 [VERIFY current Board publications], the Board has not issued a comprehensive standalone policy on commercial stem cell, PRP, NAD+, or peptide therapy. Standard practice-of-medicine and informed-consent rules apply. The Board’s licensure verification and complaint portals are accessible through mn.gov.

Minnesota’s Right to Try Law

Minnesota enacted Right to Try legislation in the 2015 legislative session [VERIFY exact statute citation in Minnesota Statutes Chapter 151 or related chapter]. The Minnesota law operates in parallel with the federal Right to Try Act of 2018 and allows eligible patients with terminal illnesses to access investigational drugs, biological products, and devices that have completed FDA Phase 1 clinical trials.

The Minnesota statute does not authorize clinics to offer unapproved stem cell, exosome, or peptide therapies outside the narrow conditions of the Act — terminal diagnosis, exhausted FDA-approved options, physician recommendation, access through the actual sponsor of an investigational product.

Minnesota’s Major Regenerative Medicine Research Centers

Minnesota’s research footprint is extensive and clinically-active:

  • Mayo Clinic Center for Regenerative Biotherapeutics (Rochester) — one of the most clinically-active regenerative medicine programs in the country. Mayo runs Phase 1 and 2 trials across multiple cell-therapy platforms, FDA-registered cell processing facilities, and a large hematologic transplantation program. Mayo Clinic regenerative medicine overview: Stem cells: What they are and what they do (Mayo Clinic). Mayo’s Blood and Marrow Stem Cell Transplantation Clinic: Mayo Clinic Minnesota.
  • University of Minnesota Stem Cell Institute (Minneapolis) — basic and translational stem cell research.
  • Masonic Cancer Center, University of Minnesota — clinical cell therapy programs.

The University of Minnesota Center for Bioethics — through faculty including Leigh Turner — has also been one of the country’s most-cited academic sources on the regulatory and ethical challenges posed by unproven commercial stem cell offerings. Critical scholarship from this group has shaped FDA enforcement priorities and informed multiple federal court decisions Stem Cell Businesses and Right to Try Laws — Experts@Minnesota.

Patients in Minnesota with an interest in legitimate experimental access should search clinicaltrials.gov for active trials at Mayo and the University of Minnesota before considering cash-pay commercial options. Mayo in particular is one of the most realistic destinations in the country for trial-based regenerative medicine access.

IV Therapy and NAD+ in Minnesota

NAD+ intravenous therapy is broadly available in Minnesota. Registered nurses may administer IV under physician orders, and Minnesota grants nurse practitioners full practice authority including independent prescribing. IV lounges, mobile IV services, and concierge IV providers operate in the Twin Cities, Rochester, Duluth, and other metros.

NAD+ itself is compounded through 503A or 503B pharmacies and is not FDA-approved for any indication. Patients pay out of pocket.

Telemedicine and Out-of-State Providers

Minnesota is a member of the Interstate Medical Licensure Compact. Minnesota residents can establish telehealth relationships with out-of-state physicians licensed through the compact. Minnesota’s own telehealth rules expanded substantially in 2020–2021 and continue to evolve.

Notable Enforcement

The FDA’s public Warning Letter database is the authoritative source for federal enforcement against specific Minnesota-based clinics [VERIFY against current list]. The 2021 federal injunction in United States v. US Stem Cell Clinic, LLC applies in Minnesota as in every state.

Minnesota has not been a notable focus of state attorney general action against the commercial regenerative medicine sector. The presence of Mayo Clinic and the University of Minnesota’s active research portfolios may have channeled significant cell-therapy activity through legitimate trial pathways rather than standalone commercial clinics.

Cost and Clinic Landscape

Regenerative medicine clinics in Minnesota cluster in the Twin Cities (Minneapolis-St. Paul), Rochester (around Mayo), Duluth, and Bloomington. Celmedica currently lists [X] verified clinics across Minnesota — pull live count.

Typical out-of-pocket pricing in Minnesota (representative ranges; individual clinics vary):

  • PRP joint injection: $500 – $1,400 per session
  • Autologous stem cell injection (single joint or area): $4,800 – $9,500
  • NAD+ IV (single drip): $400 – $900
  • Peptide protocols: $200 – $1,200 per month, varies by compound

Insurance generally does not cover regenerative therapies. Some orthopedic indications for PRP are occasionally covered.

Mayo Clinic and University of Minnesota clinical-trial participation, where eligible, is often substantially cheaper or free, and is a meaningful first option to investigate.

Frequently Asked Questions

Is stem cell therapy legal in Minnesota? Minnesota has no statute prohibiting commercial stem cell therapy. Practitioners operate under federal FDA rules and Minnesota Board of Medical Practice standards. Whether a specific therapy is legal turns on whether the product falls under FDA Section 361 or 351 and on the credentials of the physician administering it.

What is Regenerative Medicine Minnesota? A state-funded legislative initiative established by the Minnesota Legislature to support research, technology development, education, and patient care in regenerative medicine. It funds projects at Minnesota institutions through annual competitive awards.

Can I access stem cell clinical trials at Mayo Clinic? Mayo Clinic operates one of the most clinically-active regenerative medicine research programs in the country. Mayo runs Phase 1 and 2 trials across multiple cell-therapy platforms; eligibility depends on the specific trial and condition. Searchable at clinicaltrials.gov.

Does Minnesota’s Right to Try law cover stem cell therapy? Only in the narrow case of investigational stem cell products that have completed FDA Phase 1 trials, for a patient with a terminal illness, accessed through the actual product sponsor. The law does not authorize a clinic to offer unapproved stem cell therapy as a routine cash-pay service.

How much does stem cell therapy cost in Minnesota? Autologous stem cell injections for a single joint typically range $4,800–$9,500 in Minnesota metros. PRP runs $500–$1,400. Mayo Clinic and University of Minnesota clinical-trial participation, where eligible, is often substantially cheaper or free.

Bottom Line

Minnesota is one of the most research-significant regenerative medicine states in the country. The Mayo Clinic Center for Regenerative Biotherapeutics, the University of Minnesota Stem Cell Institute, and the state-funded Regenerative Medicine Minnesota initiative together create an unusually rich infrastructure for legitimate cell-therapy access. For commercial stem cell therapy, the federal framework dominates; Minnesota adds its own Right to Try statute and Board of Medical Practice rules. Patients should focus on physician credentials, FDA product classification of the specific therapy, and — given Minnesota’s exceptional trial access — whether Mayo or UMN clinical trials are available before considering cash-pay commercial options.

Next steps:

[FTC affiliate disclosure block]: Some links in this guide may earn Celmedica a commission at no additional cost to you. Read our affiliate disclosure.

[Medical disclaimer]: This guide is for informational purposes and does not constitute legal or medical advice. State laws and regulatory guidance change. Verify current rules with the Minnesota Board of Medical Practice and the FDA, and consult a qualified physician before pursuing any therapy.

References

For the federal regulatory citations, see the federal baseline references.

Minnesota-specific: